Gynecologic Oncology Practice Questions

Q: Which tumor is associated with an increased risk of endometrial carcinoma?

Granulosa theca cell tumor. **Explanation:** The correct answer is **Granulosa theca cell tumor**. **1. Why it is correct:** Granulosa theca cell tumors (GTCT) are the most common type of **Sex Cord-Stromal Tumors**. These tumors are functionally active and characteristically secrete high levels of **estrogen**. Chronic, unopposed estrogenic stimulation leads to endometrial hyperplasia, which can progress to **Endometrial Carcinoma** (specifically Type I endometrioid adenocarcinoma). Approximately 5–10% of women with GTCT are found to have a coexisting endometrial carcinoma, while up to 25–50% may have endometrial hyperplasia. **2. Why the other options are incorrect:** * **Sertoli-Leydig cell tumor:** These are androgen-secreting sex cord-stromal tumors. They typically cause **virilization** (hirsutism, clitoromegaly, deepening of voice) rather than estrogenic effects. * **Immature teratoma:** This is a germ cell tumor composed of tissues from all three germ layers, specifically containing immature neural elements. It is not hormonally active in a way that affects the endometrium. * **Gonadoblastoma:** This tumor usually arises in dysgenetic gonads (e.g., Turner syndrome with Y chromosome). While it can be associated with other germ cell tumors (like dysgerminoma), it does not typically secrete estrogen. **3. Clinical Pearls for NEET-PG:** * **Tumor Marker:** **Inhibin (Inhibin B)** is the most specific marker for Granulosa cell tumors. * **Histology:** Look for **Call-Exner bodies** (small follicles filled with eosinophilic material) and "coffee-bean" nuclei. * **Presentation:** In children, it causes **precocious puberty**; in postmenopausal women, it causes **postmenopausal bleeding**. * **Endometrial Biopsy:** Always mandatory in patients diagnosed with GTCT to rule out synchronous endometrial malignancy.

Q: A patient complains of post-coital bleeding. On per speculum examination, no growth is seen. What is the next step in management?

Colposcopy with biopsy. **Explanation:** The clinical presentation of **post-coital bleeding** is a classic "red flag" symptom for cervical pathology, most notably cervical intraepithelial neoplasia (CIN) or early-stage cervical cancer. **1. Why Colposcopy with Biopsy is correct:** In a patient with post-coital bleeding, the primary objective is to rule out malignancy. Even if the cervix appears grossly normal on per speculum examination (no visible growth), microscopic or pre-invasive lesions may still be present. **Colposcopy** allows for magnified visualization of the transformation zone, and a **directed biopsy** of any acetowhite areas or abnormal vascular patterns is the gold standard for definitive diagnosis. **2. Why other options are incorrect:** * **Conization:** This is a therapeutic or diagnostic procedure (large wedge of tissue) used when colposcopy is unsatisfactory or there is a discrepancy between cytology and biopsy. It is not the initial step. * **Repeat Pap smear:** A Pap smear is a screening tool with a significant false-negative rate. In a symptomatic patient (post-coital bleeding), one must proceed directly to a diagnostic test (colposcopy) rather than relying on screening. * **Culdoscopy:** This is an obsolete endoscopic procedure used to visualize pelvic organs through the posterior vaginal fornix; it has no role in evaluating the cervical mucosa. **Clinical Pearls for NEET-PG:** * **Most common cause of post-coital bleeding:** Cervical polyps (benign), but **Cervical Cancer** must be ruled out first. * **Management Algorithm:** Symptomatic patient → Colposcopy; Asymptomatic patient with abnormal Pap → Colposcopy. * **Transformation Zone:** This is the most common site for cervical neoplasia and the primary area of interest during colposcopy.

Q: Which of the following statements regarding choriocarcinoma is true?

Lung metastasis can cause hemoptysis.. **Explanation:** **Choriocarcinoma** is a highly malignant, epithelial tumor arising from chorionic villi. It is characterized by the absence of villi and the presence of sheets of anaplastic syncytiotrophoblasts and cytotrophoblasts. **1. Why Option C is Correct:** Choriocarcinoma is a highly vascular tumor that spreads primarily via the **hematogenous route**. The **lungs** are the most common site of metastasis (80%). These metastatic lesions are often hemorrhagic; when they erode into the bronchial tree, they present clinically as cough, dyspnea, or **hemoptysis**. On a chest X-ray, these typically appear as "cannonball metastases." **2. Why Other Options are Incorrect:** * **Option A:** While aggressive, choriocarcinoma is considered one of the most **curable** cancers due to its extreme sensitivity to chemotherapy. It does not have the "worst" prognosis compared to other gestational trophoblastic neoplasias (GTN) like Placental Site Trophoblastic Tumor (PSTT), which is chemoresistant. * **Option B & D:** The primary treatment for choriocarcinoma is **chemotherapy** (e.g., Methotrexate for low-risk or EMA-CO regimen for high-risk). Surgery (Hysterectomy) and Radiotherapy are generally reserved for chemoresistant cases or localized complications (e.g., uncontrollable uterine hemorrhage). **Clinical Pearls for NEET-PG:** * **Tumor Marker:** Serum **beta-hCG** is the most sensitive marker for diagnosis and monitoring. * **Common Sites of Metastasis:** Lungs (80%) > Vagina (30%) > Pelvis (20%) > Liver (10%) > Brain (10%). * **Vaginal Metastasis:** Often presents as highly vascular, "purplish" nodules; biopsy should be avoided due to the risk of torrential hemorrhage. * **FIGO Staging:** Uses the WHO Prognostic Scoring System to categorize patients into Low-risk (<7) or High-risk (≥7).

Q: Which of the following is NOT associated with a high risk of ovarian cancer?

Multiparity. ### Explanation The correct answer is **Multiparity**. **1. Why Multiparity is the Correct Answer:** Multiparity is a **protective factor** against ovarian cancer. The underlying medical concept is the **"Incessant Ovulation" theory**. Each ovulation causes minor trauma to the ovarian surface epithelium, necessitating repair and increasing the risk of genetic mutations. Pregnancy and lactation suppress ovulation, providing the ovaries with "rest." Therefore, more pregnancies (multiparity) lead to fewer lifetime ovulations, significantly reducing the risk of epithelial ovarian cancer. **2. Why the Other Options are Wrong:** * **Endometriosis (Option A):** This is a known risk factor, specifically for **Clear Cell** and **Endometrioid** carcinomas. The chronic inflammatory environment and oxidative stress within endometriotic cysts (chocolate cysts) promote malignant transformation. * **Smoking (Option B):** While not strongly linked to all types, smoking is a significant risk factor for **Mucinous ovarian cancer**. * **Obesity (Option C):** A high BMI is associated with an increased risk of several cancers, including ovarian. This is likely due to chronic low-grade inflammation and increased peripheral conversion of androgens to estrone in adipose tissue. **3. NEET-PG High-Yield Clinical Pearls:** * **Most Protective Factor:** Combined Oral Contraceptive Pills (OCPs) reduce the risk by ~50% if used for 5+ years. * **Genetic Risk:** BRCA1 (40% lifetime risk) and BRCA2 (15-20% lifetime risk) are the strongest genetic predictors. * **Lynch Syndrome (HNPCC):** Associated with an increased risk of ovarian, endometrial, and colon cancers. * **Protective Factors:** Multiparity, OCPs, Breastfeeding, Salpingectomy, and Tubal Ligation. * **Risk Factors:** Nulliparity, Early menarche, Late menopause, HRT, and Family history.

Q: A 40-year-old female presents with abnormal cervical cytology, with a Pap smear suggestive of CIN 3. What is the next step in management?

Colposcopy and biopsy. **Explanation:** The management of abnormal cervical cytology follows the principle of **"See and Treat"** or the diagnostic triad of Cytology, Colposcopy, and Histopathology. 1. **Why Option B is Correct:** CIN 3 (Cervical Intraepithelial Neoplasia Grade 3) is a high-grade squamous intraepithelial lesion (HSIL). A Pap smear is merely a screening tool and is not diagnostic. Therefore, any high-grade abnormality on cytology must be confirmed by **Colposcopy-directed biopsy**. This is the "Gold Standard" to determine the actual histological grade of the lesion and to rule out invasive malignancy before definitive treatment is planned. 2. **Why Other Options are Incorrect:** * **Option A:** HPV testing and follow-up are appropriate for low-grade lesions (like ASC-US) or as part of co-testing. For a high-grade lesion like CIN 3, delaying diagnosis by 3 months is contraindicated due to the high risk of progression to invasive cancer. * **Option C:** Hysterectomy is an over-treatment for CIN 3. The standard treatment for confirmed CIN 3 is a fertility-sparing excisional procedure like **LEEP** (Loop Electrosurgical Excision Procedure) or **Cold Knife Conization**. Hysterectomy is only considered if there are other uterine indications or if margins remain positive after conization. * **Option D:** Surgery with chemoradiation is the management for advanced invasive cervical cancer, not for a pre-invasive intraepithelial lesion. **High-Yield Clinical Pearls for NEET-PG:** * **CIN 1:** Usually managed by observation (repeat Pap in 1 year) as most regress spontaneously. * **CIN 2/3:** Requires treatment (Ablation or Excision). * **Bethesda System:** CIN 2 and CIN 3 are collectively categorized as **HSIL** (High-grade Squamous Intraepithelial Lesion). * **Transformation Zone:** The most common site for cervical cancer; this area must be visualized during colposcopy for the exam to be considered "satisfactory."

Q: Which of the following patients presenting for routine gynecological examination in the OPD does NOT require a Pap smear, given that none have had cervical cancer screening in the past 5 years?

A 19-year-old sexually active woman. **Explanation:** The correct answer is **D. A 19-year-old sexually active woman.** According to current international guidelines (ACOG, ASCCP) and standard oncological protocols, cervical cancer screening should **begin at age 21**, regardless of the age of sexual debut. In women younger than 21, the prevalence of HPV is high, but the immune system usually clears the infection spontaneously. Screening this age group leads to unnecessary procedures (colposcopies/biopsies) for transient lesions that would have regressed naturally, causing potential harm like cervical insufficiency. **Analysis of Options:** * **Option A (35-year-old):** Screening is mandatory for women aged 21–65. Between ages 30–65, the preferred method is co-testing (Pap + HPV DNA) every 5 years or Pap alone every 3 years. * **Option B (60-year-old):** Screening continues until age 65. Since she hasn't been screened in 5 years, she requires a smear to ensure she meets the criteria to "exit" screening (3 consecutive negative Paps or 2 negative co-tests). * **Option C (28-year-old):** HPV vaccination does **not** change screening protocols. Vaccines do not protect against all oncogenic HPV types; therefore, vaccinated women must follow the same screening schedule as unvaccinated women. **High-Yield Clinical Pearls for NEET-PG:** * **Start Age:** 21 years (regardless of sexual activity). * **End Age:** 65 years (if adequate prior screening is documented). * **Post-Hysterectomy:** Screening is discontinued if the hysterectomy was for benign reasons and the cervix was removed. If the cervix remains (Supracervical Hysterectomy), screening continues. * **HIV/Immunocompromised:** Screening starts at the time of diagnosis/onset of sexual activity and is performed more frequently (annually).

Q: What is the best management for a 40-year-old lady with CIN III?

Total abdominal hysterectomy. **Explanation:** **CIN III (Cervical Intraepithelial Neoplasia Grade III)** represents severe dysplasia and carcinoma in situ. The management depends significantly on the patient's age and fertility desires. **Why Total Abdominal Hysterectomy (TAH) is the correct answer:** In a 40-year-old woman who has likely completed her family, **Total Abdominal Hysterectomy** is considered the definitive treatment for CIN III. While conservative methods like conization are preferred for younger patients wishing to preserve fertility, TAH provides the lowest risk of recurrence and eliminates the need for long-term, intensive cytological follow-up in a patient of this age group. **Analysis of Incorrect Options:** * **A. Conization:** This is the treatment of choice for younger patients who desire **fertility preservation**. In a 40-year-old, it is an alternative but less definitive than TAH. * **B. Wertheim’s Hysterectomy:** This is a radical hysterectomy used for **invasive cervical cancer** (Stage IA2 to IIA). It is overtreatment for CIN III, which is a pre-invasive lesion. * **C. Punch Biopsy:** This is a **diagnostic tool**, not a therapeutic one. It is used to confirm the grade of CIN but cannot treat it. **High-Yield Clinical Pearls for NEET-PG:** * **CIN I:** Usually managed by observation (60-80% regress spontaneously). * **CIN II/III:** Requires treatment (Ablative like Cryotherapy/LASER or Excisional like LEEP/Conization). * **Definitive Treatment:** Hysterectomy is the definitive management for CIN III in women who have completed their family or where follow-up is difficult. * **Microinvasive Carcinoma (Stage IA1):** If the depth is <3mm and no LVSI, TAH is also the treatment of choice.

Question 1

Which tumor is associated with an increased risk of endometrial carcinoma?

Accepted Answer

Granulosa theca cell tumor

Answer

Sertoli Leydig cell tumor

Answer

Immature teratoma

Answer

Gonadoblastoma tumor

Question 2

Which of the following statements is true regarding carcinoma of the cervix involving the parametrium but without pelvic sidewall involvement?

Accepted Answer

Radiotherapy should be given

Answer

Stage II

Answer

Stage IIB

Answer

Hysterectomy can be useful

Question 3

A patient complains of post-coital bleeding. On per speculum examination, no growth is seen. What is the next step in management?

Accepted Answer

Colposcopy with biopsy

Answer

Conization

Answer

Repeat Pap smear

Answer

Culdoscopy

Question 4

Which female genital malignancy is most common in pregnancy?

Accepted Answer

Cervical cancer

Answer

Ovarian cancer

Answer

Vaginal vulvar cancer

Answer

Endometrial cancer

Question 5

Which of the following statements regarding choriocarcinoma is true?

Accepted Answer

Lung metastasis can cause hemoptysis.

Answer

It has the worst prognosis.

Answer

The treatment of choice is hysterectomy.

Answer

Radiotherapy is the preferred treatment.

Question 6

Which of the following is NOT associated with a high risk of ovarian cancer?

Accepted Answer

Multiparity

Answer

Endometriosis

Answer

Smoking

Answer

Obesity

Question 7

A 40-year-old female presents with abnormal cervical cytology, with a Pap smear suggestive of CIN 3. What is the next step in management?

Accepted Answer

Colposcopy and biopsy

Answer

Test for HPV and follow up after 3 months

Answer

Hysterectomy

Answer

Surgery with adjuvant chemoradiation

Question 8

Which of the following patients presenting for routine gynecological examination in the OPD does NOT require a Pap smear, given that none have had cervical cancer screening in the past 5 years?

Accepted Answer

A 19-year-old sexually active woman

Answer

A 35-year-old woman

Answer

A 60-year-old woman

Answer

A 28-year-old woman vaccinated for HPV

Question 9

What is the treatment of choice in a 56-year-old woman with endometrial cancer?

Accepted Answer

Panhysterectomy

Answer

Irradiation

Answer

Wertheim's hysterectomy

Answer

Irradiation and later panhysterectomy

Question 10

What is the best management for a 40-year-old lady with CIN III?

Accepted Answer

Total abdominal hysterectomy

Answer

Conization

Answer

Wertheim's hysterectomy

Answer

Punch biopsy

Gynecologic Oncology — MCQs

Gynecologic Oncology — MCQs

On this page

Practice by Chapter

Want unlimited practice?